Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 4,0414,060 of 20,252 grants

Active NON-SBIR/STTR RPGS
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
NATIONAL CANCER INSTITUTE George Washington University United States 2023 – 2028

ABSTRACT Women with germline mutations of BRCA1 have about an 80% lifetime risk of developing breast cancer. All somatic cells in a germline BRCA1 mutation carrier harbor the same...

$6.15M
USD
Active NON-SBIR/STTR RPGS
Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity
NATIONAL CANCER INSTITUTE University of Tennessee Health Sci Ctr United States 2023 – 2028

Glioblastoma (GBM) is the most common primary malignancy of the adult brain and is among the most devastating cancers as it is invariably lethal. The perivascular niche and necroti...

$5.04M
USD
Active NON-SBIR/STTR RPGS
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
NATIONAL CANCER INSTITUTE University of Florida United States 2023 – 2028

PROJECT SUMMARY Gene expression, the flow of genetic information from DNA to messenger RNA (mRNA) to protein, involves delicate regulation by a group of small RNAs named microRNAs....

$816.2K
USD
Active NON-SBIR/STTR RPGS
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

PROJECT SUMMARY Cancer cells are the organizers of their surroundings and create a tumor microenvironment (TME) favoring cell division even when oxygen and nutrients are limiting....

$685K
USD
Completed NON-SBIR/STTR RPGS
Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer.
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Lung cancer remains the leading cause of cancer-related deaths in the U.S. and worldwide. Non–small cell lung cancer (NSCLC) accounts for approximately 85%...

$1.83M
USD
Active NON-SBIR/STTR RPGS
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

PROJECT SUMMARY Cancer cells are the organizers of their surroundings and create a tumor microenvironment (TME) favoring cell division even when oxygen and nutrients are limiting....

$6.64M
USD
Active NON-SBIR/STTR RPGS
Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2028

In Minnesota, American Indian (34.1%) and non-Hispanic Black (33.4%) women are over twice as likely to be obese during pregnancy than non-Hispanic White women of whom 16.6% are obe...

$3.55M
USD
Active NON-SBIR/STTR RPGS
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY Early interventions for high-risk B-cell malignancies, including diffuse large B cell lymphoma (DLBCL), Burkitt's Lymphoma (BL), and B-cell acute lymphoblastic...

$4.38M
USD
Active TRAINING, INDIVIDUAL
Obscurin-Deficient Breast Epithelia Generate Secreted Factors that Prime Lung Vascular Smooth Muscle Cell Pre-metastatic Microenvironment Formation
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2023 – 2026

Project Summary/Abstract: New therapies blocking metastatic spread are greatly needed to improve breast cancer patient survival. Pre-metastatic niche development has been identifie...

$458.1K
USD
Active NON-SBIR/STTR RPGS
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
NATIONAL CANCER INSTITUTE Magee-Women'S Res Inst and Foundation United States 2023 – 2028

Most ovarian cancer (OvCa) patients develop fatal chemotherapy-resistant disease. Elucidating mechanisms of chemoresistance in OvCa may identify therapeutic targets to prevent or t...

$4.38M
USD
Completed NON-SBIR/STTR RPGS
Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer.
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Lung cancer remains the leading cause of cancer-related deaths in the U.S. and worldwide. Non–small cell lung cancer (NSCLC) accounts for approximately 85%...

$2.1M
USD
Active NON-SBIR/STTR RPGS
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
NATIONAL CANCER INSTITUTE Magee-Women'S Res Inst and Foundation United States 2023 – 2028

Most ovarian cancer (OvCa) patients develop fatal chemotherapy-resistant disease. Elucidating mechanisms of chemoresistance in OvCa may identify therapeutic targets to prevent or t...

$4.14M
USD
Active NON-SBIR/STTR RPGS
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
NATIONAL CANCER INSTITUTE George Washington University United States 2023 – 2028

ABSTRACT Women with germline mutations of BRCA1 have about an 80% lifetime risk of developing breast cancer. All somatic cells in a germline BRCA1 mutation carrier harbor the same...

$5.84M
USD
Active NON-SBIR/STTR RPGS
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY Early interventions for high-risk B-cell malignancies, including diffuse large B cell lymphoma (DLBCL), Burkitt's Lymphoma (BL), and B-cell acute lymphoblastic...

$4.16M
USD
Active NON-SBIR/STTR RPGS
Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity
NATIONAL CANCER INSTITUTE University of Tennessee Health Sci Ctr United States 2023 – 2028

Glioblastoma (GBM) is the most common primary malignancy of the adult brain and is among the most devastating cancers as it is invariably lethal. The perivascular niche and necroti...

$4.83M
USD
Active NON-SBIR/STTR RPGS
Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2028

In Minnesota, American Indian (34.1%) and non-Hispanic Black (33.4%) women are over twice as likely to be obese during pregnancy than non-Hispanic White women of whom 16.6% are obe...

$3.37M
USD
Active NON-SBIR/STTR RPGS
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

PROJECT SUMMARY Cancer cells are the organizers of their surroundings and create a tumor microenvironment (TME) favoring cell division even when oxygen and nutrients are limiting....

$6.24M
USD
Active TRAINING, INDIVIDUAL
Obscurin-Deficient Breast Epithelia Generate Secreted Factors that Prime Lung Vascular Smooth Muscle Cell Pre-metastatic Microenvironment Formation
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2023 – 2026

Project Summary/Abstract: New therapies blocking metastatic spread are greatly needed to improve breast cancer patient survival. Pre-metastatic niche development has been identifie...

$470.9K
USD
Active NON-SBIR/STTR RPGS
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinoma
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

PROJECT SUMMARY Immune checkpoint inhibitors (ICIs) targeting the PD-1 pathway have transformed the management of many advanced cancers, including renal cell carcinoma (RCC), but m...

$6.28M
USD
Completed NON-SBIR/STTR RPGS
Elucidating the relevance of BARD1-PLK1 interaction in PDAC and response to therapy
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2023 – 2025

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options. The overall 5-year survival rate is only 11% and there is an unmet need for...

$780K
USD